| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 12.94× | 12.94× | 11.84× | 19.56× | 30.95× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.44× | 0.44× | 0.43× | 0.37× | 0.35× | ||
| 0.88× | 0.88× | 0.84× | 0.83× | 0.81× | ||
| 0.77× | 0.77× | 0.74× | 0.82× | 0.71× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 30.95 | 19.56 | 11.84 | 12.94 | 12.94 | |
| Asset Turnover | 0.35 | 0.37 | 0.43 | 0.44 | 0.44 | |
| Cash Conversion (CFO/Net Income) | 0.81 | 0.83 | 0.84 | 0.88 | 0.88 | |
| CFO/EBITDA | 0.71 | 0.82 | 0.74 | 0.77 | 0.77 |